Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

Clinical trial NCT05924594 · SUSPENDED

Trial details

NCT number: NCT05924594
Sponsor: Cingulate Therapeutics
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

ADHD ADHD - Combined Type Attention Deficit Hyper Activity Attention Deficit Hyperactivity Disorder Attention Deficit Disorder With Hyperactivity Attention Deficit Hyperactivity Disorder Combined Attention-deficit Hyperactivity

Start date: 2023-07-31
Primary completion: 2027-02-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.